These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 35483477)
1. Pharmacological effects of cannabidiol by transient receptor potential channels. Etemad L; Karimi G; Alavi MS; Roohbakhsh A Life Sci; 2022 Jul; 300():120582. PubMed ID: 35483477 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
3. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals. Galaj E; Xi ZX Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481 [TBL] [Abstract][Full Text] [Related]
4. Pure Δ Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155 [TBL] [Abstract][Full Text] [Related]
5. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692 [TBL] [Abstract][Full Text] [Related]
6. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874 [TBL] [Abstract][Full Text] [Related]
7. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related]
8. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854 [TBL] [Abstract][Full Text] [Related]
10. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors. Fride E; Ponde D; Breuer A; Hanus L Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887 [TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Campos AC; Moreira FA; Gomes FV; Del Bel EA; Guimarães FS Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3364-78. PubMed ID: 23108553 [TBL] [Abstract][Full Text] [Related]
14. Diversity of molecular targets and signaling pathways for CBD. de Almeida DL; Devi LA Pharmacol Res Perspect; 2020 Dec; 8(6):e00682. PubMed ID: 33169541 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT Galaj E; Bi GH; Yang HJ; Xi ZX Neuropharmacology; 2020 May; 167():107740. PubMed ID: 31437433 [TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium. Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159 [TBL] [Abstract][Full Text] [Related]
17. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. McPartland JM; Duncan M; Di Marzo V; Pertwee RG Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544 [TBL] [Abstract][Full Text] [Related]
18. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review. Dos Santos RG; Hallak JEC; Crippa JAS Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002 [TBL] [Abstract][Full Text] [Related]
20. Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA Masoumi M; Manavi MA; Mohammad Jafari R; Mirzaei A; Hedayatyanfard K; Beigmohammadi MT; Dehpour AR Cannabis Cannabinoid Res; 2024 Jun; 9(3):797-808. PubMed ID: 37976207 [No Abstract] [Full Text] [Related] [Next] [New Search]